Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy and Safety of PEMbrolizumab PD-L1-positive (>50% of Tumor Cells), Advanced NSCL Cancer(PEMBREIZH)

University Hospital, Brest · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
carcinomaimmunotherapypembrolizumab
carcinoma, non-small-cell lung, immunotherapy, pembrolizumab, first line treatment, pdl1 tps > 50%, brain efficacy, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1045209
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.